|
|
|
| Day 1 |
|
Tuesday, October 19, 2010 |
| |
PVD
|
8:00 AM - 8:05 AM | |
Welcome to VIVA 2010
|
8:05 AM - 8:15 AM | |
Key Note Address: Why Specializing in Vascular Disease is the Right Decision: Evolutionary Advances in 2011
Speaker: Timothy Sullivan, MD
|
8:15 AM - 8:25 AM | |
Extreme VIVA
|
8:25 AM - 8:35 AM | |
The Ethics of Live Case Demonstrations: Are We Doing the Right Thing?
Speaker: Jeremy Sugarman, MD
|
8:35 AM - 9:45 AM | |
LIVE CASE DEMONSTRATIONS Moderator: Tony Das, MD; Krishna Rocha-Singh, MD
Panel: D. Christopher Metzger, MD; Mahmood Razavi, MD; John Rundback, MD; Benjamin Starnes, MD; Christopher White, MD
|
9:45 AM - 9:55 AM | |
Hybrid Endovascular Cases: Why and When is This The Best Option
Speaker: Karthik Kasirajan, MD
|
9:55 AM - 10:05 AM | |
Making Crossing Long CTO's Routine: Techniques and Variables That You Need to Know if You Are Going to Offer This Treatment to Patients
Speaker: John Rundback, MD
|
10:05 AM - 10:30 AM | |
REFRESHMENT BREAK
|
10:30 AM - 10:50 AM | |
DISCUSSION: The Evolution of Atherectomy Devices
|
| | | | | Position 1: Why We Need Data Before Widespread Use: Mahmood Razavi, MD |
|
| | | | | Position 2: I Don't Need to Wait For p Values For These Devices; When and Where I Use Atherectomy While the Data is Being Generated: D. Christopher Metzger, MD |
|
| | | | | Refereed Commentary: John Laird, MD |
|
10:50 AM - 12:00 PM | |
LIVE CASE DEMONSTRATIONS Moderator: Gary Ansel, MD; Michael R. Jaff, DO
Panel: Steven Dean, DO; Karthik Kasirajan, MD; Barry Katzen, MD; Dierk Scheinert, MD
|
12:00 PM - 1:30 PM | |
LUNCH/SATELLITE SYMPOSIA
|
1:30 PM - 1:50 PM | |
DEBATE: Infrainguinal Bypass
|
| | | | | Position 1: Why Surgical Bypass Should Be the First Choice: Benjamin Starnes, MD |
|
| | | | | Position 2: With the Latest Trial Data Endovascular Should Usually Be the First Option: Jon Matsumura, MD |
|
| | | | | Refereed Commentary: Michael Dake, MD |
|
1:50 PM - 2:00 PM | |
Will Drug-Coated Balloons, Drug-Coated Stents or New Stent Designs Change the Landscape in SFA Treatment? What We Have to Look Forward To
Speaker: Barry Katzen, MD
|
2:00 PM - 3:15 PM | |
LIVE CASE DEMONSTRATIONS Moderator: Michael Dake, MD; Manish Mehta, MD
Panel: Michael R. Jaff, DO; Zvonimir Krajcer, MD; Alan Lumsden, MD; Bob Smouse, MD; Timothy Sullivan, MD
|
3:15 PM - 3:35 PM | |
REFRESHMENT BREAK
|
3:35 PM - 3:55 PM | |
DEBATE: Optimal Treatment for Complex Aorto-Iliac Disease
|
| | | | | Position 1: Aortobifemoral Bypass Remains the Gold Standard: Michel Makaroun, MD |
|
| | | | | Position 2: Newer Endovascular Devices Are Making Aortobifemoral Bypass Obsolete: Bob Smouse, MD |
|
| | | | | Refereed Commentary: Tony Das, MD |
|
3:55 PM - 4:00 PM | |
Extreme VIVA
|
4:00 PM - 4:10 PM | |
Vascular Access and Closure: The Keys to Staying Percutaneous for Most Device Sizes
Speaker: Zvonimir Krajcer, MD
|
4:10 PM - 5:30 PM | |
LIVE CASE DEMONSTRATIONS Moderator: John Laird, MD; Manish Mehta, MD
Panel: Mark Burket, MD; Zvonimir Krajcer, MD; Michel Makaroun, MD; Alan Matsumoto, MD; Yoshiaki Yokoi, MD
|
|
|